Featured Research

from universities, journals, and other organizations

Potential new target for schizophrenia drugs identified

Date:
June 11, 2010
Source:
Rockefeller University
Summary:
Scientists have identified a protein that boosts the signaling power of a receptor involved in relaying messages between brain cells, a finding that suggests a new target for the development of treatments for schizophrenia and Parkinson's disease. The protein, called Norbin, directly interacts with a receptor for the neurotransmitter glutamate, which is critical to the process by which individual brain cells send messages to one another and plays a key role in learning and memory.

Rockefeller University scientists have identified a protein that boosts the signaling power of a receptor involved in relaying messages between brain cells, a finding that suggests a new target for the development of treatments for schizophrenia and Parkinson's disease. The protein, called Norbin, directly interacts with a receptor for the neurotransmitter glutamate, which is critical to the process by which individual brain cells send messages to one another and plays a key role in learning and memory.

Receptors such as the one linked to Norbin, known as mGluR5, are proteins that are embedded in the plasma membrane of a cell and respond to small molecules called ligands. As mGluR5 binds to its ligand it responds by changing its shape, which ultimately leads to the initiation of an intracellular signal. Several classes of receptors exist, the most common of which is the G-protein coupled receptor (GPCR).

"Proteins that modulate GPCR functions are becoming as important as the receptors themselves because they represent novel therapeutic targets," says Marc Flajolet, a senior research associate in Rockefeller's Laboratory of Molecular and Cellular Neuroscience headed by Paul Greengard. "About half of the drugs commercially available today target this group."

Glutamate, one of the most important neurotransmitters, acts through several GPCRs. These receptors are involved in normal processes such as development, learning and memory, as well as in various diseases.

Flajolet and first author Hong Wang searched for proteins that physically interact with mGluR5 and found several, including Norbin. The researchers paired Norbin and mGluR5 in cultured neurons and found that Norbin not only stimulated mGluR5 activity but also increased the amount of mGluR5 on the surface of the neurons.

Fajolet and Wang then looked at Norbin's effects on mGluR5 in the adult mouse brain, and found Norbin in the hippocampus, amygdala, septum and nucleus accumbens, similar to where mGluR5 is typically found.

The researchers went on to create conditional knockout mice, which are genetically engineered to shut off Norbin production after birth. These mice showed deficits in synaptic plasticity and behavior similar to those found in a rodent model of schizophrenia. For example, the Norbin knockouts were startled by a loud noise as much as normal mice, but were unable to suppress a startle response with subsequent exposure to noise.

"Our work further demonstrates the importance of GPCR regulatory proteins," says Flajolet. "We are now investigating the mechanism by which Norbin affects mGluR5 and are searching for regulatory pathways that could modify Norbin function and, indirectly, mGluR5 activity."


Story Source:

The above story is based on materials provided by Rockefeller University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wang et al. Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling. Science, 2009; 326 (5959): 1554 DOI: 10.1126/science.1178496

Cite This Page:

Rockefeller University. "Potential new target for schizophrenia drugs identified." ScienceDaily. ScienceDaily, 11 June 2010. <www.sciencedaily.com/releases/2010/04/100427113305.htm>.
Rockefeller University. (2010, June 11). Potential new target for schizophrenia drugs identified. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/2010/04/100427113305.htm
Rockefeller University. "Potential new target for schizophrenia drugs identified." ScienceDaily. www.sciencedaily.com/releases/2010/04/100427113305.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Possible Ebola Patient in Isolation at California Hospital

Possible Ebola Patient in Isolation at California Hospital

Reuters - US Online Video (Aug. 20, 2014) — A patient who may have been exposed to the Ebola virus is in isolation at the Kaiser Permanente South Sacramento Medical Center. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Raw: World's Oldest Man Lives in Japan

Raw: World's Oldest Man Lives in Japan

AP (Aug. 20, 2014) — A 111-year-old Japanese was certified as the world's oldest man by Guinness World Records on Wednesday. Sakari Momoi, a native of Fukushima in northern Japan, was given a certificate at a hospital in Tokyo. (Aug. 20) Video provided by AP
Powered by NewsLook.com
Do More Wedding Guests Make A Happier Marriage?

Do More Wedding Guests Make A Happier Marriage?

Newsy (Aug. 20, 2014) — A new study found couples who had at least 150 guests at their weddings were more likely to report being happy in their marriages. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) — Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins